Quick Answer
CONMED Corp reported Research And Development Expense of $55.88 million for the year ending 2025.
- CONMED Corp showed an increase of +2.7% in Research And Development Expense from 2024 to 2025.
- This data is from CONMED Corp's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $6.44 million | Q3 2010: $7.40 million | Q1 2011: $7.68 million | Q2 2011: $6.80 million | Q3 2011: $7.02 million | Q1 2012: $7.10 million | Q2 2012: $7.19 million | Q3 2012: $7.08 million | Q1 2013: $5.69 million | Q2 2013: $6.59 million | Q3 2013: $7.11 million | Q1 2014: $6.91 million | Q2 2014: $6.85 million | Q3 2014: $6.91 million | Q1 2015: $6.54 million | Q2 2015: $7.50 million | Q3 2015: $6.65 million | Q1 2016: $8.26 million | Q2 2016: $8.01 million | Q3 2016: $8.35 million | Q1 2017: $7.62 million | Q2 2017: $8.04 million | Q3 2017: $8.27 million | Q1 2018: $7.71 million | Q2 2018: $9.99 million | Q3 2018: $14.12 million | Q1 2019: $10.58 million | Q2 2019: $11.81 million | Q3 2019: $10.99 million | Q1 2020: $10.12 million | Q2 2020: $8.70 million | Q3 2020: $9.94 million | Q1 2021: $10.03 million | Q2 2021: $11.32 million | Q3 2021: $10.86 million | Q1 2022: $10.67 million | Q2 2022: $11.49 million | Q3 2022: $12.77 million | Q1 2023: $12.54 million | Q2 2023: $13.57 million | Q3 2023: $12.46 million | Q1 2024: $13.59 million | Q2 2024: $14.10 million | Q3 2024: $13.56 million | Q1 2025: $12.95 million | Q2 2025: $14.14 million | Q3 2025: $13.90 million.
- Over the full 17 years of available data (2009 to 2025), CONMED Corp's Research And Development Expense has grown by 75.5%.
- Historical annual values: Fiscal year 2025: $55.88 million | Fiscal year 2024: $54.43 million | Fiscal year 2023: $52.60 million | Fiscal year 2022: $47.15 million | Fiscal year 2021: $43.57 million | Fiscal year 2020: $40.47 million | Fiscal year 2019: $45.46 million | Fiscal year 2018: $42.19 million | Fiscal year 2017: $32.31 million | Fiscal year 2016: $32.25 million | Fiscal year 2015: $27.44 million | Fiscal year 2014: $27.78 million | Fiscal year 2013: $25.83 million | Fiscal year 2012: $28.21 million | Fiscal year 2011: $28.65 million | Fiscal year 2010: $29.65 million | Fiscal year 2009: $31.84 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: